Search hospitals

>

Colorado

>

Denver

Porter Adventist Hospital

Claim this profile

Denver, Colorado 80210

Global Leader in Breast Cancer

Global Leader in Lung Cancer

Conducts research for Breast cancer

Conducts research for Cancer

Conducts research for Prostate Cancer

388 reported clinical trials

5 medical researchers

Photo of Porter Adventist Hospital in DenverPhoto of Porter Adventist Hospital in Denver

Summary

Porter Adventist Hospital is a medical facility located in Denver, Colorado. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Prostate Cancer and other specialties. Porter Adventist Hospital is involved with conducting 388 clinical trials across 499 conditions. There are 5 research doctors associated with this hospital, such as Richard L. Deming, Shahzad Siddique, Douglas Dennis, MD, and Mehmet S. Copur.

Area of expertise

1

Breast Cancer

Global Leader

Porter Adventist Hospital has run 70 trials for Breast Cancer. Some of their research focus areas include:

HER2 negative
ER positive
Stage IV
2

Lung Cancer

Global Leader

Porter Adventist Hospital has run 56 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage II
Stage I

Top PIs

Clinical Trials running at Porter Adventist Hospital

Bladder Cancer

Lung Cancer

Prostate Cancer

Breast Cancer

Multiple Myeloma

Pancreatic Cancer

Esophageal cancer

Bladder Carcinoma

Breast cancer

Melanoma

Image of trial facility.

Eribulin + Chemotherapy

for Bladder Cancer

This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.

Recruiting

2 awards

Phase 3

Image of trial facility.

Gemcitabine + Cisplatin

for Bladder Cancer

This phase II trial studies how well gemcitabine hydrochloride and cisplatin work in treating participants with invasive bladder urothelial cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Recruiting

1 award

Phase 2

Image of trial facility.

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Porter Adventist Hospital?

Where is Porter Adventist Hospital located?

Who should I call to ask about financial aid or insurance network?

What insurance does Porter Adventist Hospital accept?

What awards or recognition has Porter Adventist Hospital received?